Treating Acute Stroke Patients With Intravenous tPA | Zendy

David Z. Wang | Zendy; Jean A. Rose | Zendy; Debra Honings | Zendy; Dennis J. Garwacki | Zendy; Joseph C. Milbrandt | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treating Acute Stroke Patients With Intravenous tPA

Author(s) -

David Z. Wang,

Jean A. Rose,

Debra Honings,

Dennis J. Garwacki,

Joseph C. Milbrandt

Publication year - 2000

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.31.1.77

Subject(s) - medicine , stroke (engine) , intracerebral hemorrhage , emergency medicine , tissue plasminogen activator , fibrinolytic agent , modified rankin scale , acute stroke , ischemic stroke , subarachnoid hemorrhage , ischemia , mechanical engineering , engineering

Since the FDA approved tissue plasminogen activator (tPA) in 1996 for acute ischemic stroke, few data have been obtained during the postmarketing phase, and applicability in rural hospitals does not exist. We attempt to examine the safety and outcome of intravenous tPA for acute ischemic stroke in the OSF Stroke Network.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research